Insider at issuer (PTCT) details Rule 144 stock sales update

Rhea-AI Filing Summary

Form 144 discloses a planned sale of 2,746 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of 213,888.74. These shares relate to an issuer with 80,288,305 common shares outstanding and are expected to be sold on or about 01/09/2026 on the NASDAQ exchange.

The securities to be sold were acquired on 01/07/2026 via restricted stock vesting from the issuer as compensation, in the same amount of 2,746 shares. The notice also lists earlier sales over the prior three months by Eric Pauwels, including 40,290 common shares sold on 12/17/2025 for gross proceeds of 3,038,755.33, along with smaller transactions on several subsequent dates in December 2025 and January 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2746	213888.74	80288305	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2026	Restricted Stock Vesting	Issuer			2746	01/07/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	12/17/2025	40290	3038755.33
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	12/18/2025	3202	240354.49
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	12/19/2025	20508	1584387.54
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/06/2026	1789	137659.26
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/07/2026	1352	104758.10
Eric Pauwels 500 Warren Corporate Center Drive Warren NJ 07059	Common	01/08/2026	4602	352062.33

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many PTCT shares are covered by this Form 144 notice?

The notice covers a planned sale of 2,746 shares of common stock, with an aggregate market value of 213,888.74 as disclosed.

When and how were the PTCT shares to be sold under Form 144 acquired?

The 2,746 common shares were acquired on 01/07/2026 through restricted stock vesting from the issuer as compensation, matching the amount now planned for sale.

What is the approximate planned sale date and trading venue for these PTCT shares?

The filer indicates an approximate sale date of 01/09/2026, with the common shares expected to be sold on the NASDAQ exchange through Fidelity Brokerage Services LLC.

How many PTCT shares are reported as outstanding in this Form 144?

The filing states that there are 80,288,305 common shares outstanding for the issuer at the time of the notice.

What prior PTCT stock sales by Eric Pauwels are disclosed in the last three months?

The filing lists several sales of common shares by Eric Pauwels, including 40,290 shares sold on 12/17/2025 for gross proceeds of 3,038,755.33, plus additional sales on 12/18/2025, 12/19/2025, 01/06/2026, 01/07/2026, and 01/08/2026.

What does the Form 144 representation about material information say?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.